These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1311574)

  • 1. Phosphorylation of a surface receptor bound urokinase-type plasminogen activator in a human metastatic carcinomatous cell line.
    Takahashi K; Kwaan HC; Ikeo K; Koh E
    Biochem Biophys Res Commun; 1992 Feb; 182(3):1466-72. PubMed ID: 1311574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells.
    Busso N; Masur SK; Lazega D; Waxman S; Ossowski L
    J Cell Biol; 1994 Jul; 126(1):259-70. PubMed ID: 7517943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon alpha induces rapid tyrosine phosphorylation of the alpha subunit of its receptor.
    Platanias LC; Colamonici OR
    J Biol Chem; 1992 Nov; 267(33):24053-7. PubMed ID: 1385434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator.
    Mahanivong C; Yu J; Huang S
    Mol Carcinog; 2007 Mar; 46(3):165-75. PubMed ID: 17186542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth factor-like effect of urokinase type plasminogen activator in human renal cells.
    He CJ; Rebibou JM; Peraldi MN; Meulders Q; Rondeau E
    Biochem Biophys Res Commun; 1991 May; 176(3):1408-16. PubMed ID: 1645544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A monoclonal antibody that recognizes the receptor binding region of human urokinase plasminogen activator.
    Nolli ML; Corti A; Soffientini A; Cassani G
    Thromb Haemost; 1986 Oct; 56(2):214-8. PubMed ID: 2433787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta 1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor.
    Falcone DJ; McCaffrey TA; Haimovitz-Friedman A; Garcia M
    J Cell Physiol; 1993 Jun; 155(3):595-605. PubMed ID: 7684044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction.
    Yebra M; Goretzki L; Pfeifer M; Mueller BM
    Exp Cell Res; 1999 Jul; 250(1):231-40. PubMed ID: 10388537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells.
    Kobayashi H; Suzuki M; Kanayama N; Nishida T; Takigawa M; Terao T
    Int J Cancer; 2002 Dec; 102(4):379-89. PubMed ID: 12402308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin.
    Biliran H; Sheng S
    Cancer Res; 2001 Dec; 61(24):8676-82. PubMed ID: 11751384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy?
    Fazioli F; Blasi F
    Trends Pharmacol Sci; 1994 Jan; 15(1):25-9. PubMed ID: 8140655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic properties of the phosphorylated urokinase-type plasminogen activator isolated from a human carcinomatous cell line.
    Takahashi K; Kwaan HC; Koh E; Tanabe M
    Biochem Biophys Res Commun; 1992 Feb; 182(3):1473-81. PubMed ID: 1540190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor.
    Falcone DJ; McCaffrey TA; Mathew J; McAdam K; Borth W
    J Cell Physiol; 1995 Aug; 164(2):334-43. PubMed ID: 7622580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pro-urokinase plasminogen-activation system in the presence of serpin-type inhibitors and the urokinase receptor: rescue of activity through reciprocal pro-enzyme activation.
    Behrendt N; List K; Andreasen PA; Danø K
    Biochem J; 2003 Apr; 371(Pt 2):277-87. PubMed ID: 12534347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
    Vines DJ; Lee SW; Dichek DA; Ellis V
    J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of human pro-urokinase on Ser138/303 impairs its receptor-dependent ability to promote myelomonocytic adherence and motility.
    Franco P; Iaccarino C; Chiaradonna F; Brandazza A; Iavarone C; Mastronicola MR; Nolli ML; Stoppelli MP
    J Cell Biol; 1997 May; 137(3):779-91. PubMed ID: 9151681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The receptor for urokinase-type plasminogen activator of a human keratinocyte line (HaCaT).
    Reinartz J; Link J; Todd RF; Kramer MD
    Exp Cell Res; 1994 Oct; 214(2):486-98. PubMed ID: 7925643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific inhibition of the activity of the urokinase receptor-mediated cell-surface plasminogen activation system by suramin.
    Ellis V; Danø K
    Biochem J; 1993 Dec; 296 ( Pt 2)(Pt 2):505-10. PubMed ID: 8257443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of human squamous cell carcinoma plasma membrane associated urokinase plasminogen activator by epidermal growth factor.
    Niedbala MJ; Bajetta S; Carbone R; Sartorelli AC
    Cancer Commun; 1990; 2(9):317-24. PubMed ID: 2169831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
    Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.